CORC

在结果中检索

CORC

浏览/检索结果: 共262条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Cs2LiLa(Br1-xClx)6:Ce稀土闪烁晶体的制备及性能研究 会议论文
中国江西赣州, 2020-10-19
作者:  沈潇;  魏钦华;  秦来顺;  史宏声
收藏  |  浏览/下载：2/0  |  提交时间：2020/11/30
DMC-PID Cascade Control Algorithm for the Constant Rate Temperature Rising Process in Differential Scanning Calorimeter 会议论文
Guilin, China, April 26-28, 2019
作者:  Wei LX(魏来星);  Hu JT(胡静涛);  Yu Y(郁洋)
收藏  |  浏览/下载：29/0  |  提交时间：2019/08/18
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：45/0  |  提交时间：2019/12/05
A Novel Algorithm to Differential Scanning Calorimeter Temperature Control Based on Liquid Nitrogen Feedforward Technique 会议论文
Zhuhai, China, May 17-19, 2019
作者:  Yu Y(郁洋);  Wei LX(魏来星);  Sun W(孙威);  Hu JT(胡静涛);  Jia Y(贾洋)
收藏  |  浏览/下载：27/0  |  提交时间：2019/09/28
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：35/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：36/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：29/0  |  提交时间：2019/12/05
PAX8 is Expressed in Less Than Half of Anaplastic Thyroid Carcinomas - Multi-Institutional Study Using Monoclonal Antibody MRQ-50 会议论文
108th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) - Unlocking Your Ingenuity, MAR 16-21, 2019
作者:  Bai, Yanhua;  Liu, Zhiyan;  Gu, Haiyan;  Jung, Chan Kwon;  Hang, Jen-Fan
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/31
PAX8 is Expressed in Less Than Half of Anaplastic Thyroid Carcinomas - Multi-Institutional Study Using Monoclonal Antibody MRQ-50 会议论文
108th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) - Unlocking Your Ingenuity, MAR 16-21, 2019
作者:  Bai, Yanhua;  Liu, Zhiyan;  Gu, Haiyan;  Jung, Chan Kwon;  Hang, Jen-Fan
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/31

©版权所有 ©2017 CSpace - Powered by CSpace